Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01439633 · ClinicalTrials.gov registry record · NA
Optical Frequency Domain Imaging (OFDI) Surveillance and Image Guided Biopsy of the Esophagus
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
NCT01439633: Completed NA study, sponsored by Massachusetts General Hospital.
NCT01439633 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 22 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01439633, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
Study Summary
The specific aim of this study is to determine the feasibility of marking target pathologic locations identified on Optical Frequency Domain Imaging (OFDI) datasets using superficial cautery marks of the esophagus that are visible by endoscopy for subsequent guidance of biopsy.
Interventions
- DEVICE MGH OFDI marking
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2010-10 |
| Est. Completion | 2014-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01439633
The ClinicalTrials.gov registry entry for NCT01439633 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MGH OFDI marking is the first listed.
NCT01439633 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01439633 about?
NCT01439633 is a clinical study titled "Optical Frequency Domain Imaging (OFDI) Surveillance and Image Guided Biopsy of the Esophagus". The specific aim of this study is to determine the feasibility of marking target pathologic locations identified on Optical Frequency Domain Imaging (OFDI) datasets using superficial cautery marks of the esophagus that are visible by endoscopy for subsequent guidance of biopsy.
What is the current status of trial NCT01439633?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2010-10. Estimated completion is 2014-05.
What interventions are being tested in trial NCT01439633?
The interventions under investigation include: MGH OFDI marking (DEVICE).
Who is sponsoring clinical trial NCT01439633?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.